Live
FierceBiotechScientists turn pig semen extract into eye drops that kill cancer in miceEndpoints NewsOtsuka buys Transcend Therapeutics for $700M upfrontEndpoints NewsCHMP recommends subcutaneous form of Sanofi's Sarclisa and four new drugsBioWorldBiopharma money raised: Jan. 1-March 26, 2026BioWorldMoney raised by biopharmaBioPharma DiveOtsuka picks up PTSD drug with $700M Transcend buyFierceBiotech'We need to put some bad ideas to bed': Inside Incubate's battles for biotech on Capitol HillFierceBiotechAfter local tumor approval, Novocure touts positive data in metastatic pancreatic cancerFierceBiotechOtsuka buys Transcend in $1.2B deal, nabbing MDMA analog for psychiatric conditionsFierceBiotechAstraZeneca’s in vivo CAR-T bet eradicates cancer in 3 of 5 patients, but death mars datasetFierceBiotechChutes & Ladders—Tang takes over Aurinia after FDA brouhahaBioWorldKorea roundup: Alteogen, Celltrion lead biotech deals
Illumina Mar 27, 2026

Vanguard realigns reporting; subsidiaries to report separately (Illumina, ILMN) - Stock Titan

Vanguard realigns reporting; subsidiaries to report separately (Illumina, ILMN) - Stock Titan

Original
Body unavailable. Use the original source.

Directory

59 All